Smith & Nephew (SNN) Other Non-Current Assets (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Other Non-Current Assets of $164.0 million for Q4 2025, up 583.33% year-on-year from $24.0 million in Q4 2024, and up 234.69% on a QoQ basis from $49.0 million in Q2 2025.
Smith & Nephew (SNN) Other Non-Current Assets (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Other Non-Current Assets for 12 consecutive years, with $164.0 million the latest figure, recorded in Q4 2025.
- Quarterly Other Non-Current Assets rose 583.33% year-over-year to $164.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $164.0 million (up 583.33% YoY) and the FY2025 annual result came in at $164.0 million, up 583.33% from the prior year.
- Other Non-Current Assets climbed to $164.0 million in Q4 2025 per SNN's latest filing, from $49.0 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for SNN reached as high as $164.0 million in Q4 2025 and fell as low as $12.0 million in Q4 2022.
- A 5-year average of $42.7 million and a median of $18.0 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2021 — Other Non-Current Assets plunged 54.55% — and 2025, when it surged 583.33%.
- Year by year, Other Non-Current Assets stood at $15.0 million in 2021, then fell by 20.0% to $12.0 million in 2022, then jumped by 50.0% to $18.0 million in 2023, then jumped by 33.33% to $24.0 million in 2024, then jumped by 583.33% to $164.0 million in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $164.0 million, $49.0 million, and $24.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 211.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 164.00 Mn |
| Jun 28, 2025 | 49.00 Mn |
| Dec 31, 2024 | 24.00 Mn |
| Jun 29, 2024 | 17.00 Mn |
| Dec 31, 2023 | 18.00 Mn |
| Dec 31, 2022 | 12.00 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Dec 31, 2020 | 33.00 Mn |
| Jun 30, 2020 | 30.00 Mn |
| Dec 31, 2019 | 35.00 Mn |
| Jun 29, 2019 | 33.00 Mn |
| Dec 31, 2018 | 16.00 Mn |
| Jun 30, 2018 | 13.00 Mn |
| Dec 31, 2017 | 16.00 Mn |
| Mar 31, 2012 | 128.00 Mn |
| Dec 31, 2011 | 125.00 Mn |
| Dec 31, 2009 | 14.00 Mn |